Black Rock Inc. Lyra Therapeutics, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LYRA
# of Institutions
57Shares Held
25MCall Options Held
56.6KPut Options Held
33.9K-
Perceptive Advisors LLC New York, NY12.8MShares$381 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.77MShares$52.8 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.39MShares$41.6 Million0.08% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$31.6 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$30.4 Million0.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $951M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...